4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000110
Chief Executive Officer sold 3,506 shares at $34.11 ($119,590)
- Chief Executive Officer returned 85,886 shares (to the company)
- Chief Executive Officer acquired 92,187 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric Chief Executive Officer | 2026-10-01 | Option exercise | +92,187 | $14.46 | $1,333,024 | 346,467 | D |
| Venker Eric Chief Executive Officer | 2026-10-01 | Returned to the company | −85,886 | $33.65 | $2,890,064 | 260,581 | D |
| Venker Eric Chief Executive Officer | 2026-10-02 | Sale | −3,506 | $34.11 | $119,590 | 257,075 | D |
| Derivatives | |||||||
| Venker Eric Chief Executive Officer | 2026-10-01 | Option exercise · Capped Value Appreciation Rights | −92,187 | 921,875 | D | ||
| Open-market sales · 3,506 sh · avg $34.11 · $119,590 | |||||||
Loading xslF345X06/wk-form4_1791243741.xml…